Financial Advocates Investment Management’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-200
| Closed | -$4.7K | – | 742 |
|
|
2023
Q1 | $4.7K | Hold |
200
| – | – | ﹤0.01% | 732 |
|
|
2022
Q4 | $5K | Hold |
200
| – | – | ﹤0.01% | 745 |
|
|
2022
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 740 |
|
|
2022
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 680 |
|
|
2022
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 724 |
|
|
2021
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 758 |
|
|
2021
Q3 | $13K | Hold |
200
| – | – | ﹤0.01% | 735 |
|
|
2021
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 718 |
|
|
2021
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 730 |
|
|
2020
Q4 | $14K | Hold |
200
| – | – | ﹤0.01% | 708 |
|
|
2020
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 616 |
|
|
2020
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 587 |
|
|
2020
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 471 |
|
|
2019
Q4 | $23K | Buy |
+200
| New | +$23K | ﹤0.01% | 504 |
|